Status:
UNKNOWN
Effects of Clomiphene Citrate Ovulation Induction on Frozen Embryo Transfer
Lead Sponsor:
ShangHai Ji Ai Genetics & IVF Institute
Conditions:
Infertility, Female
Clomiphene Citrate
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
Clomiphene citrate has been widely used for treatment of infertility for decades. Although its anti-estrogenic effects leads to low pregnancy rate, clomiphene citrate is still a first-line treatment f...
Detailed Description
This study receives patients from 2017 August to 2018 June who undergo ART treatment at Shanghai Jiai Genetics \& IVF Institute and taken either CC or GnRH antagonist protocol(control group) for ovula...
Eligibility Criteria
Inclusion
- Women 18-40 years of age who are scheduled for IVF or ICSI in our IVF institute while meeting the following criteria:
- AMH ≥ 2;
- Infertility factors: tubal factor, severe oligospermia, etc;
- FET cycle;
- Cleavage stage embryo transfer (Day 3).
Exclusion
- BMI ≤ 18.4 or ≥ 25.0;
- Have pregnancy complications;
- Genital tract malformations, uterine cavity diseases, PCOS;
- Endometriosis;
- Genetic diseases, severe somatic diseases, mental disorder.
Key Trial Info
Start Date :
August 7 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2018
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT03309436
Start Date
August 7 2017
End Date
June 30 2018
Last Update
October 13 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Jiai Genetics & IVF Institute
Shanghai, China, 200011